Glutamate Receptor 6 Antibody (818235) [Unconjugated]

CHO cell line transfected with human GluR6/GRIK2 was stained with Mouse Anti-Human GluR6/GRIK2 Monoclonal Antibody (Catalog # MAB9610, filled histogram) or Mouse IgG2A isotype control antibody (MAB003, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (F0102B). Staining was performed using our Staining Membrane-associated Proteins protocol.

• Reactivity: Hu
• Applications: Flow
• Clone: 818235
• Clonality: Monoclonal
• Host: Mouse
• Conjugate: Unconjugated

Glutamate Receptor 6 Antibody (818235) [Unconjugated] Summary

• Immunogen: Chinese Hamster Ovary cell line CHO-derived human GluR6/GRIK2 protein
  Thr32 - Asn549
  Accession # Q13002
• Specificity: Detects human GluR6/GRIK2 in cell-based ELISAs.
• Source: N/A
• Isotype: IgG2a
• Clonality: Monoclonal
• Host: Mouse
• Purity Statement: Protein A or G purified from hybridoma culture supernatant

Applications/Dilutions

• Dilutions:
  • Flow Cytometry 0.25 ug/10^6 cells

Packaging, Storage & Formulations

• Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
• Reconstitution Instructions: Reconstitute at 0.5 mg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Glutamate Receptor 6 Antibody (818235) [Unconjugated]

• EAA4
• GLR6
• GluK2
• GLUK6
• GluR6
• glutamate receptor 6
• glutamate receptor, ionotropic, kainate 2
• ionotropic kainate 2
• MGC74427
• MRT6

Background

The Ionotropic Glutamate Receptors are a family of ligand-gated ion channels involved in regulating fast excitatory synaptic transmission in the central nervous system (CNS) (1, 2). The family consists of ~18 members which is divided into 3 groups based on the activating agonist: N-Methyl-D-Aspartate (NMDA), alpha -Amino-3-hydroxy-5-Methyl-4-isoxazole Propionic Acid (AMPA) and kainate (KA) (1, 2). KA receptors (KAR) are found in the pre- and postsynaptic membranes of the central nervous system, most prominently in the hippocampus, where they regulate synaptic transmission, neuronal excitability, and network activity (3). Glutamate receptor 6 (GluR6) (also Glutamate receptor ionotropic, kainate 2 or GluK2) along with GluR5, GluR7 and receptor subunits KA1 and KA2 belong to the KAR sub-group as these molecules are activated by kainic acid (1-3). Mature human GluR6 is a 3-transmembrane protein with a long (530 aa) N-terminal extracellular domain (ECD), a M2 domain involved in pore formation and a short C-terminal intracellular domain (4). The ECD of human GluR6 is highly conserved and shares 99% identity with both mouse and rat. Under physiological conditions, GluR6 forms either a homomeric or heteromeric receptor channel with GluR5 or KA1/2 to become functional (5, 6). Activation of KAR complexes result in Ca2⁺-dependent release of glutamatergic or GABAergic signals (7). The modulatory role of KARs make them attractive therapeutic candidates as glutamate excitotoxicity has been associated with multiple neurodegenerative and mental disorders. Misregulation of GluR6 has been suggested to be a factor in autism, Huntington disease and epilepsy (8). Additionally, GluR6 has been suggested to play a role in tumor suppression in Gastric cancer (9) while potentially displaying the opposite effect in urological cancers (10).

1. Dingledine, R. et al. (1999) Pharmacol Rev. 51(1):7.
2. Traynelis, S.F. et al. (2010) Pharmacol Rev. 62(3):405.
3. Contractor, A. et al. (2011) Trends Neurosci. 34(3):154.
4. Nanao, M.H. et al. (2005) PNAS 102(5):1708.
5. Kumar, J. et al. (2011) Neuron. 71(2):319.
6. Fisher, J.L. et al. (2011) J. Neurosci. 31(47):17113.
7. Mathew, S.S. and Hablitz, J.J. (2008) Neuropharmacology. 55(1):106.
8. Lerma, J. and Marques, J.M. (2013) Neuron. 80(2):292.
9. Wu, C.S. et al. (2010) Int J Cancer. 126(11):2542.
10. Inoue, R. et al. (2017) Oncotarget. 8(17):28826.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Uniprot:
  • Q13002(Human)